For example, the application of CD33-CAR-NK92 cells in patients with relapsed or refractory acute myeloid leukemia (AML) resulted in fever (reaching up to 40°C) and grade I CRS, accompanied by increased serum levels of IL-10 and IL-17. This evidence concerns the gene CD33 and acute myeloid leukemia.